SS 09 - CNS 2: CNS Metastases and Normal Tissue Toxicity

Moderator(s)

• 

  William Breen, MD

  Mayo Clinic Rochester
  Rochester, Minnesota
• 

  Peter Chen, MD, FASTRO, FASTRO, FACR

  Corewell Health William Beaumont University Hospital
  Bloomfield Hills, Michigan, United States

Presentations:

• 4:45 PM – 4:55 PM ET

  Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Metastasis- Final Analysis of a Phase II Study
  

  Presenter: Jonathan Yang, MD, PhD – New York University School of Medicine
• 4:55 PM – 5:05 PM ET

  Risk of Radiation Myelitis after Hypofractionated Spine Stereotactic Body Radiation Therapy
  

  Presenter: Christopher Jackson, MD, MS – Memorial Sloan Kettering Cancer Center
• 5:05 PM – 5:15 PM ET

  Evaluating Neurocognitive Recovery Following Stereotactic Radiosurgery and Whole Brain Radiation Therapy: Insights from a Pooled Analysis of Three Phase III Trials
  

  Presenter: Hua-Ren Cherng, MD – University of Maryland Medical Center
• 5:15 PM – 5:25 PM ET

  Neurocognition and Quality of Life for Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity vs. Whole-Brain Radiotherapy (WBRT) Following Brain Metastasis Resection - Results of
  

  Presenter: Rami El Shafie, MD – University Medical Center Gottingen (UMG)
• 5:25 PM – 5:35 PM ET

  A Longitudinal Study to Correlate Neurocognitive Changes of IDH-Mutant and IDH-Wildtype Glioma Patients after Chemoradiotherapy with Changes on Resting-State MRI
  

  Presenter: Zhihua Liu, PhD – Washington University School of Medicine in St Louis
• 5:35 PM – 5:45 PM ET

  Assessing Atrophy and Neurocognitive Decline in Hippocampal Subfields after Fractionated Brain Radiation Therapy
  

  Presenter: Hieu Nguyen, BS – UCSD School of Medicine
• 5:45 PM – 5:55 PM ET

  Discussant
  

  Discussant: Kristin Redmond, MD, MPH – Johns Hopkins University